As Chemocentryx (CCXI) Stock Value Declined, Bvf Lowered Holding; As Disney Walt Co (DIS) Share Value Rose, Kemper Master Retirement Trust Raised Its Stake by $2.39 Million

The Walt Disney Company (NYSE:DIS) Logo

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 3.41% based on its latest 2019Q2 regulatory filing with the SEC. Bvf Inc sold 50,000 shares as the company’s stock declined 38.33% . The hedge fund held 1.41 million shares of the health care company at the end of 2019Q2, valued at $13.16M, down from 1.46M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $440.03 million market cap company. The stock increased 2.08% or $0.15 during the last trading session, reaching $7.55. About 169,426 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has declined 28.17% since October 10, 2018 and is downtrending. It has underperformed by 28.17% the S&P500. Some Historical CCXI News: 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in

Kemper Corp Master Retirement Trust increased its stake in Disney Walt Co (DIS) by 172.02% based on its latest 2019Q2 regulatory filing with the SEC. Kemper Corp Master Retirement Trust bought 17,202 shares as the company’s stock rose 4.86% . The institutional investor held 27,202 shares of the television services company at the end of 2019Q2, valued at $3.80M, up from 10,000 at the end of the previous reported quarter. Kemper Corp Master Retirement Trust who had been investing in Disney Walt Co for a number of months, seems to be bullish on the $234.09 billion market cap company. The stock increased 0.48% or $0.62 during the last trading session, reaching $129.95. About 1.60M shares traded. The Walt Disney Company (NYSE:DIS) has risen 26.97% since October 10, 2018 and is uptrending. It has outperformed by 26.97% the S&P500. Some Historical DIS News: 29/05/2018 – DISNEY SAID PREPARED TO OFFER SIGNIFICANT CASH IF NEEDED: CNBC; 08/05/2018 – WALT DISNEY CO – QTRLY LOWER OPERATING INCOME IN CABLE NETWORKS PRIMARILY DUE TO A LOSS AT BAMTECH AND DECREASES AT FREEFORM AND ESPN; 14/03/2018 – Disney announces strategic reorganization, effective immediately; 25/04/2018 – WALT DISNEY CO DIS.N : BMO RAISES TO MARKET PERFORM FROM UNDERPERFORM; 03/04/2018 – Dealbook: Disney Offers to Buy Sky News to Aid Rupert Murdoch’s Bid for Sky; 08/03/2018 – WELLS’ RYVICKER: SKY IS MORE IMPORTANT TO COMCAST THAN DISNEY; 05/03/2018 – Disney names James Pitaro as ESPN president; 05/03/2018 – Ratings for Sunday’s Oscars telecast plunge, early data shows; 16/05/2018 – JUST IN: 21st Century Fox says Lachlan Murdoch will be chairman & CEO of “New Fox” after company sells majority of its assets to The Walt Disney Company; Rupert Murdoch to serve as co-chairman of the new company; 16/05/2018 – TWENTY-FIRST CENTURY FOX INC FOXA.O – FOX CEO JAMES MURDOCH TO QUIT AFTER DISNEY DEAL TO PURSUE SOMETHING OF HIS OWN

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on November, 14. They expect $-0.27 EPS, down 22.73% or $0.05 from last year’s $-0.22 per share. After $-0.26 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 3.85% negative EPS growth.

Bvf Inc, which manages about $999.89M and $915.61M US Long portfolio, upped its stake in Cidara Therapeutics Inc by 942,211 shares to 2.65 million shares, valued at $4.46 million in 2019Q2, according to the filing. It also increased its holding in Xoma Corp Del by 27,913 shares in the quarter, for a total of 1.80 million shares, and has risen its stake in Merus N V.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2019 Results – Earnings Call Transcript – Seeking Alpha” on August 05, 2019, also Globenewswire.com with their article: “ChemoCentryx to Present at Two Upcoming Investor Conferences – GlobeNewswire” published on August 29, 2019, Fool.com published: “Here’s Why ChemoCentryx Rose as Much as 53.5% Today – The Motley Fool” on January 04, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “The Chemokine Concept – ChemoCentryx, Inc. (NASDAQ:CCXI) – Seeking Alpha” published on February 03, 2014 as well as Seekingalpha.com‘s news article titled: “Insulet and Invacare among healthcare gainers; Endo International and InspireMD among losers – Seeking Alpha” with publication date: August 06, 2019.

Investors sentiment increased to 1.89 in 2019 Q2. Its up 0.45, from 1.44 in 2019Q1. It increased, as 9 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 46 raised stakes. 36.18 million shares or 8.54% more from 33.34 million shares in 2019Q1 were reported. Gsa Prtn Llp holds 0.06% or 60,622 shares in its portfolio. 17,811 are owned by Sectoral Asset. D E Shaw Company Incorporated has invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Consonance Capital Mgmt Ltd Partnership has invested 1.1% in ChemoCentryx, Inc. (NASDAQ:CCXI). State Of Wisconsin Investment Board owns 30,800 shares. Commercial Bank Of Montreal Can holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 78,890 shares. Meeder Asset Mngmt invested in 0% or 4,543 shares. Barclays Public Ltd Company stated it has 82,440 shares or 0% of all its holdings. Sg Americas Securities Lc accumulated 20,171 shares. Fosun accumulated 128,637 shares. The Connecticut-based Paw Cap has invested 0.6% in ChemoCentryx, Inc. (NASDAQ:CCXI). Dimensional Fund Advisors Lp holds 1.04 million shares. 25,907 are owned by Amer Gru. Jacobs Levy Equity Mngmt reported 65,890 shares. Deutsche National Bank Ag accumulated 0% or 129,386 shares.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *